Evaluation of antibody response to the heptavalent pneumococcal conjugate vaccine in pediatric chronic kidney disease.
Pneumococcal vaccination has been recommended for immunocompromised children, including patients with chronic kidney disease. We determined pneumococcal immunoglobulin (Ig)G antibodies to serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F before and after 48 pediatric patients with chronic renal failure were administered heptavalent conjugated pneumococcal vaccine. The patients were between 1 and 9 years of age and were separated into a conservative treatment group (Group 1) and a dialysis group (Group 2). The antibody response to the vaccinal serotypes was evaluated by measuring antibody concentrations before the first dose and 60 days after the second one. Pre-vaccinal IgG concentrations > or = 0.35 microg/ml were detected for all serotypes in at least 50% of the patients in both groups. Patients from both groups showed a statistically indistinguishable behavior in terms of the medians of post-vaccination IgG levels. An "adequate" vaccine response was defined as a post-immunization level of specific pneumococcal serotype antibody > or = 0.35 microg/ml, based on the World Health Organization's (WHO) protective antibody concentration definition for pneumococcal conjugate vaccines, or on a fourfold increase over baseline for at least five of the seven antigens of the vaccine. An "adequate" vaccinal response was obtained in 100% of the patients of both groups using WHO's definition, or in 45.8% of Group 1 patients and 37.5% of Group 2 patients when the criterion was a fourfold antibody increase over baseline antibody concentrations.
Vieira
Simone
S
Pediatric Nephrology Unit, Instituto da Criança do Hospital das Clinicas da Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Baldacci
Evandro Roberto
ER
Carneiro-Sampaio
Magda
M
Doria Filho
Ulysses
U
Koch
Vera Hermina
VH
D000907:Antibodies, Bacterial / Q000097:blood*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D016867:Immunocompromised Host; D007074:Immunoglobulin G / Q000097:blood; D007223:Infant; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000276:immunology* / Q000503:physiopathology; D011008:Pneumococcal Infections / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000276:immunology*; D011446:Prospective Studies; D012703:Serotyping; D013296:Streptococcus pneumoniae / Q000145:classification / Q000276:immunology*; D018074:Vaccines, Conjugate / Q000276:immunology*
D000907:Antibodies, Bacterial; D007074:Immunoglobulin G; D022242:Pneumococcal Vaccines; D018074:Vaccines, Conjugate
J Lab Clin Med. 1980 Aug;96(2):363-70
7400669
Curr Opin Immunol. 1999 Apr;11(2):180-5
10322154
Nephrol Dial Transplant. 1989;4(3):216-21
2498780
Microb Drug Resist. 1997 Summer;3(2):141-6
9185141
Pediatrics. 2008 Jul;122(1):e26-32
18595971
Pediatr Infect Dis J. 2000 Mar;19(3):187-95
10749457
Lancet. 2005 Mar 26-Apr 1;365(9465):1139-46
15794968
Semin Nephrol. 1998 May;18(3):256-63
9613866
Pediatr Nephrol. 1992 Mar;6(2):179-81
1571217
N Engl J Med. 2003 Oct 2;349(14):1341-8
14523142
Pediatr Nephrol. 2004 Dec;19(12):1334-9
15503181
Nephrol Dial Transplant. 1996 Mar;11(3):468-73
8671817
Pediatr Infect Dis J. 2002 Feb;21(2):141-7
11840082
Kidney Int Suppl. 2001 Feb;78:S206-11
11169012
Vaccine. 2007 Mar 8;25(12):2194-212
17267077
Clin Microbiol Infect. 2006 Jan;12(1):50-5
16460546
Pediatr Infect Dis J. 2003 Feb;22(2):141-9
12586978
Vaccine. 2007 May 10;25(19):3816-26
17368878
Pediatr Infect Dis J. 1987 Jun;6(6):519-26
3615065
Braz J Infect Dis. 1998 Apr;2(2):90-96
11101916
Clin Diagn Lab Immunol. 1999 Jan;6(1):50-4
9874663
Dtsch Med Wochenschr. 2008 Feb;133(8):358-62
18270917
Lancet. 2003 Aug 2;362(9381):355-61
12907008
Pediatr Pulmonol. 1996 Sep;22(3):167-73
8893255
J Infect Dis. 2002 Apr 1;185(7):927-36
11920317
J Pediatr. 1996 May;128(5 Pt 1):649-53
8627437
Nephron. 1975;14(2):195-208
1079332
J Allergy Clin Immunol. 1998 Aug;102(2):215-21
9723664
Clin Nephrol. 1983 Jun;19(6):288-94
6603319
Pediatr Clin North Am. 1987 Jun;34(3):571-90
3588043
J Infect Dis. 2003 Apr 15;187(8):1206-12
12695999